Hostname: page-component-5b777bbd6c-w9n4q Total loading time: 0 Render date: 2025-06-18T22:40:33.521Z Has data issue: false hasContentIssue false
  • English
  • Français

Ivabradine treatment for an infant with potential accessory pathway-related refractory supraventricular tachycardia

Published online by Cambridge University Press:  03 June 2025

Ayse Sulu Open the ORCID record for Ayse Sulu [Opens in a new window] ,
Pelin Kosger Open the ORCID record for Pelin Kosger [Opens in a new window] ,
Eylem Kiral  and
Birsen Ucar Open the ORCID record for Birsen Ucar [Opens in a new window]
Ayse Sulu*
Affiliation:
Eskisehir Osmangazi University, Department of Pediatric Cardiology, Eskisehir, Turkey
Pelin Kosger
Affiliation:
Eskisehir Osmangazi University, Department of Pediatric Cardiology, Eskisehir, Turkey
Eylem Kiral
Affiliation:
Eskisehir Osmangazi University, Department of Pediatric Intensive Care, Eskisehir, Turkey
Birsen Ucar
Affiliation:
Eskisehir Osmangazi University, Department of Pediatric Cardiology, Eskisehir, Turkey
*
Corresponding author: Ayse Sulu; Email: suluayse@windowslive.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Ivabradine has been shown to be safe and effective in treating congenital and postoperative junctional ectopic tachycardia in children; however, in recent years, case reports have suggested that it may also be used to treat automaticity-related ectopic atrial tachycardia and focal atrial tachycardia. Here, we discussed a case in which we used ivabradine to induce sinus rhythm in a 38-day-old baby who had resistant supraventricular tachycardia and investigated potential accessory pathway-related tachycardia.

Keywords

Ivabradinesupraventricular tachycardiachildren
Type
Brief Report
Information
Cardiology in the Young , First View , pp. 1 - 4
Check for updates
Copyright
© The Author(s), 2025. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Nawarskas, JJ, Bowman, BN, Anderson, JR. Ivabradine: a unique and intriguing medication for treating cardiovascular disease. Cardiol Rev 2015; 23: 201–211.CrossRefGoogle ScholarPubMed
Ergul, Y, Ozturk, E, Ozgur, S, Ozyurt, A, Cilsal, E, Guzeltas, A. Ivabradine is an effective antiarrhythmic therapy for congenital junctional ectopic tachycardia-induced cardiomyopathy during infancy: case studies. Pacing Clin Electrophysiol 2018; 41: 1372–1377.CrossRefGoogle Scholar
Hackett, G, Lin, TK, Imundo, JR. Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease. HeartRhythm Case Rep 2022; 8: 415–419.CrossRefGoogle Scholar
Michel, H, Heißenhuber, F, Wellmann, S, Melter, M, Gerling, S. Ectopic atrial tachycardia in a 12-month-old girl treated with ivabradine and beta-blocker, a case report. Front Pediatr 2020; 8: 313.CrossRefGoogle Scholar
Cohen, MI, Cohen, JA, Shope, C, Stollar, L, Collazo, L. Ivabradine as a stabilising anti-arrhythmic agent for multifocal atrial tachycardia. Cardiol Young 2020; 30: 899–902.CrossRefGoogle ScholarPubMed
Xu, X, Guo, Y, Gao, W, Huang, M, Liu, T, Li, F. Ivabradine monotherapy in pediatric patients with focal atrial tachycardia: a single-center study. Eur J Pediatr 2023; 182: 2265–2271.CrossRefGoogle ScholarPubMed
Krishna, MR, Kunde, MF, Kumar, RK, Balaji, S. Ivabradine in post-operative junctional ectopic tachycardia (JET): breaking new ground. Pediatr Cardiol 2019; 40: 1284–1288.CrossRefGoogle ScholarPubMed
Arvind, B, Kothari, SS, Juneja, R, et al. Ivabradine versus amiodarone in the management of postoperative junctional ectopic tachycardia: a randomized, open-label, noninferiority study. JACC Clin Electrophysiol 2021; 7: 1052–1060.CrossRefGoogle ScholarPubMed
Fontenla, A, Tamargo, J, Salgado, R, et al. Ivabradine for controlling heart rate in permanent atrial fibrillation: a translational clinical trial. Heart Rhythm 2023; 20: 822–830.CrossRefGoogle ScholarPubMed
Kamisah, Y, Che Hassan, HH. Therapeutic use and molecular aspects of ivabradine in cardiac remodeling: a review. Int J Mol Sci 2023; 24: 2801.CrossRefGoogle ScholarPubMed
Di Marco, GM, De Nigris, A, Pepe, A, Pagano, A, Di Nardo, G, Tipo, V. Ivabradine-flecainide as breakthrough drug combination for congenital junctional ectopic tachycardia: a case report and literature review. Pediatr Rep 2021; 13: 624–631.CrossRefGoogle ScholarPubMed
Tolani, D, Ramdat Misier, NL, Alqahtani, M, et al. Early experience with ivabradine for focal atrial tachycardia in pediatric patients with congenital heart disease. Heart Rhythm 2024; 21: 115–116.CrossRefGoogle ScholarPubMed
Doctor, P, Scott, WA, Tindel, K, Nguyen, HH. Ivabradine overdose in a newborn: precautions of dispensing in infants. Cardiol Res 2022; 13: 242–245.CrossRefGoogle Scholar